4.7 Article

EnDuo, a novel derivative of Endostar, inhibits the migration of colon cancer cells, suppresses matrix metalloproteinase-2/9 expression and impedes AKT/ERK activation

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Downregulation of miR-133 via MAPK/ERK signaling pathway involved in nicotine-induced cardiomyocyte apoptosis

Lu Wang et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)

Article Oncology

Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer

Jianghong Wu et al.

CURRENT CANCER DRUG TARGETS (2013)

Article Cell Biology

Matrine Inhibits Breast Cancer Growth Via miR-21/PTEN/Akt Pathway in MCF-7 Cells

Lin-Qiang Li et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)

Article Oncology

Global Cancer Statistics

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2011)

Review Chemistry, Medicinal

Natural Products and Colon Cancer: Current Status and Future Prospects

Subapriya Rajamanickam et al.

DRUG DEVELOPMENT RESEARCH (2008)

Article Ophthalmology

Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor - induced migration of uveal melanoma cells

Mao Ye et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)

Article Oncology

Adjuvant therapy of colon cancer: Current status and future directions

Ki Young Chung et al.

CANCER JOURNAL (2007)

Article Pharmacology & Pharmacy

Focal adhesion kinase: A potential target in cancer therapy

Maroesja J. van Nimwegen et al.

BIOCHEMICAL PHARMACOLOGY (2007)

Review Oncology

Molecular mechanisms of resistance and toxicity associated with platinating agents

Cara A. Rabik et al.

CANCER TREATMENT REVIEWS (2007)

Article Gastroenterology & Hepatology

A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer

Simone Spaderna et al.

GASTROENTEROLOGY (2006)

Review Oncology

Matrix metalloproteinases and tumor metastasis

EI Deryugina et al.

CANCER AND METASTASIS REVIEWS (2006)

Review Biotechnology & Applied Microbiology

Exploiting the PI3K/AKT pathway for cancer drug discovery

BT Hennessy et al.

NATURE REVIEWS DRUG DISCOVERY (2005)

Review Oncology

Mechanisms of disease: inflammatory mediators and cancer prevention

JR Mann et al.

NATURE CLINICAL PRACTICE ONCOLOGY (2005)

Review Cell Biology

The activation of Akt/PKB signaling pathway and cell survival

G Song et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)

Review Biochemistry & Molecular Biology

PI3K-Akt pathway: Its functions and alterations in human cancer

M Osaki et al.

APOPTOSIS (2004)

Article Dentistry, Oral Surgery & Medicine

MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells

P Nyberg et al.

JOURNAL OF DENTAL RESEARCH (2002)

Review Oncology

Dissemination and growth of cancer cells in metastatic sites

AF Chambers et al.

NATURE REVIEWS CANCER (2002)

Review Oncology

The phosphatidylinositol 3-kinase-AKT pathway in human cancer

I Vivanco et al.

NATURE REVIEWS CANCER (2002)

Review Oncology

Epithelial-mesenchymal transitions in tumour progression

JP Thiery

NATURE REVIEWS CANCER (2002)

Article Biochemistry & Molecular Biology

Endostatin binds to the catalytic domain of matrix metalloproteinase-2

SJ Lee et al.

FEBS LETTERS (2002)

Article Pharmacology & Pharmacy

Inhibition of protein kinase B/Akt: implications for cancer therapy

MM Hill et al.

PHARMACOLOGY & THERAPEUTICS (2002)

Review Biochemistry & Molecular Biology

The role of collagen-derived proteolytic fragments in angiogenesis

AG Marneros et al.

MATRIX BIOLOGY (2001)

Article Biochemistry & Molecular Biology

Generation and degradation of human endostatin proteins by various proteinases

M Ferreras et al.

FEBS LETTERS (2000)